Evidence map›Paper›PMID 38534507›Full record

ArticleBioengineering (Basel, Switzerland)2024

Point-of-Need Additive Manufacturing in Austere Arctic Environments: An Evaluation of Medical Logistics Requirements and Capabilities Demonstration.

Cate Wisdom, Nicholas Chartrain, Kelli Blaize-Wise, George J Klarmann, Kristin H Gilchrist, Vincent B Ho

Abstract read
In one paragraph

Article in Bioengineering (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Cate Wisdom4DBio3 Center for Biotechnology, Uniformed Services University of the Health Sciences, 9410 Key West Ave., Suite 150, Rockville, MD 20850, USA.ORCID 0000-0002-4361-7161
Nicholas Chartrain4DBio3 Center for Biotechnology, Uniformed Services University of the Health Sciences, 9410 Key West Ave., Suite 150, Rockville, MD 20850, USA.ORCID 0000-0002-2799-0580
Kelli Blaize-Wise4DBio3 Center for Biotechnology, Uniformed Services University of the Health Sciences, 9410 Key West Ave., Suite 150, Rockville, MD 20850, USA.
George J Klarmann4DBio3 Center for Biotechnology, Uniformed Services University of the Health Sciences, 9410 Key West Ave., Suite 150, Rockville, MD 20850, USA.ORCID 0000-0001-9614-9464
Kristin H Gilchrist4DBio3 Center for Biotechnology, Uniformed Services University of the Health Sciences, 9410 Key West Ave., Suite 150, Rockville, MD 20850, USA.ORCID 0000-0003-3584-9832
Vincent B Ho4DBio3 Center for Biotechnology, Uniformed Services University of the Health Sciences, 9410 Key West Ave., Suite 150, Rockville, MD 20850, USA.

Funding

Uniformed Services University of the Health Sciences HU00011920022
6 · The paper itself

Abstract

Medical response to military conflicts, natural disasters, and humanitarian crises are challenged by operational logistics with unreliable supply chains, delayed medical evacuation, and compatibility of the disparate medical equipment and consumables. In these environments, stocks of supplies will become more quickly depleted and the need for equipment parts increases secondary to their higher likelihood for failure from overuse. Additive Manufacturing (AM), or 3D printing, at or closer to the point-of-need provides potential solutions to mitigate these logistics challenges. AM's ability to tailor the resultant product through computer design enables real-time modification of a product to meet a specific situation. In this study, we deployed two different 3D printers to an arctic locale to demonstrate the utility of 3D printing and bioprinting in austere environments. Deployment of AM solutions in austere environments will likely impact medical care following natural disasters and conflicts with contested logistics. The work presented here furthers the readiness status of AM for use in austere environments to manufacture medical equipment parts and demonstrates its potential use for tissue engineering and advanced medical treatments in remote environments.

Indexed as

3D printingadditive manufacturingaustere operationsbioprintingmedical logisticspoint-of-need manufacturing

Identifiers

PMID38534507
PMCPMC10968242

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.